Using ultrasound to improve detection of fetal growth issues

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the structured use of ultrasound scanning to enhance the detection of fetal growth restriction during pregnancy. It focuses on the Oxford Growth Restriction Pathway (OxGRIP), which aims to improve the identification of growth-restricted babies, a significant risk factor for stillbirth. The study analyzes routinely collected clinical data from pregnant women receiving antenatal care at the Oxford University Hospitals NHS Foundation Trust over a six-year period. By evaluating the effectiveness of this clinical care pathway, the study seeks to address the current low detection rates of fetal growth issues.

Why it matters

Who can join: the full rules

Inclusion Criteria:

• All pregnant women receiving antenatal care at the Oxford University Hospitals NHS Foundation Trust (OUHFT) from January 2013 to 31st December 2019 with no exclusion criteria

Exclusion Criteria:

* Women who have opted out of research related to pregnancy in this pregnancy whilst receiving care by the OUHFT.
* If intrapartum care takes place outside of the OUHFT.

Where it's running

• Oxford University Hospitals NHS Foundation Trust
  Oxford, Oxfordshire, United Kingdom Recruiting

Study contacts

• Study coordinator: Lawrence Impey
• Email: lawrence.impey@ouh.nhs.uk
• Phone: 01865 851165

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving intrapartum care in Ethiopia to reduce stillbirths and maternal deaths

  This study is testing a new approach to improve care during childbirth in Ethiopia to see if it can help reduce stillbirths and keep mothers safer.

  Recruiting Haramaya Unversity · Harar, Oromiya and 1 other locations · NCT06273007

• Maternal supplementation to improve fetal brain development in growth-restricted pregnancies

  This study is testing if giving pregnant women supplements to help their babies' brain development can improve outcomes for babies who are not growing well in the womb.

  Recruiting at 6 sites Institut d'Investigacions Biomèdiques August Pi i Sunyer · Barcelona and 5 other locations · NCT05038462

• Screening and planned delivery to prevent preeclampsia at term

  This study is testing a new blood test to see if it can help predict preeclampsia in first-time pregnant women and if inducing labor early can lower the chances of complications for both mom and baby.

  Recruiting at 8 sites Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Liège and 20 other locations · NCT04766866

• Using aspirin to prevent complications in pregnant women with chronic hypertension

  This study is testing whether taking low-dose aspirin during pregnancy can help prevent serious complications for women with chronic high blood pressure and their babies.

  Recruiting at 14 sites Phase 3 Centre Hospitalier Intercommunal Creteil · Bordeaux and 19 other locations · NCT04356326

• Monitoring fetal heart activity in high-risk pregnancies to prevent stillbirth

  This study is testing a new way to monitor fetal heart activity in high-risk pregnancies to see if it can help prevent stillbirth.

  Recruiting at 2 sites Medical College of Wisconsin · Madison, Wisconsin and 1 other locations · NCT03775954

• Preeclampsia Biomarker Test in African Women

  This study tests whether measuring the sFlt-1/PlGF ratio using quick clinic tests helps predict which pregnant women in Africa will develop severe preeclampsia.

  Recruiting Africa Clinical Research Network (ACRN) · Harare, Harare · NCT07810439

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.